4900
C.-N. Chen et al. / Bioorg. Med. Chem. 18 (2010) 4897–4904
2.4.5. Date for 8e
(m, 2H, Ar-H), 7.36 (s, 1H, Ar-H), 7.76 (s, 1H, Het-H), 10.69 (s, 1H,
NH); EI MS: m/z (%) 351 (M+, 5.0), 307 (9.4), 237 (9.3), 148
(48.7), 141 (61.5), 140 (100), 139 (67.3), 117 (42.2), 105 (89.5),
91 (25.3), 77 (71.0). Anal. Calcd for C14H14ClN5O2S: C, 47.80; H,
4.01; N, 19.91. Found: C, 48.09; H, 4.31; N, 19.80.
Yeild: 25.0%; mp 163–164 °C; 1H NMR (400 MHz, CDCl3): d 3.09
(s, 3H, CH3), 6.96–7.47 (m, 2H, Ar-H), 7.60 (s, 1H, Het-H), 8.06 (s,
1H, NH); EI MS: m/z (%) 411 (M+, 91), 391 (69), 390 (53), 318
(44), 290 (24), 261 (24), 209 (100), 161 (22), 146 (99), 101 (96),
91 (36), 72 (36), 70 (21), 45 (24), 42 (43). Anal. Calcd for
C
13H7F6N5O2S: C, 37.96; H, 1.72; N, 17.03. Found: C, 38.06; H,
2.4.14. Date for 8n
Yeild: 27.4%; mp 177–178 °C; 1H NMR (600 MHz, DMSO-d6): d
2.61 (s, 3H, CH3), 2.86 (s, 3H, CH3), 7.11–7.33 (m, 3H, Ar-H), 7.75
(s, 1H, Het-H), 11.28 (s, 1H, NH); EI MS: m/z (%) 340 ([M+1],
23.6), 339 (M+, 98.7), 338 ([Mꢁ1], 70.5), 274 (41.8), 255 (51.2),
181 (27.7), 148 (67.3), 127 (100), 100 (31.3), 69 (21.2), 57 (31.9).
Anal. Calcd for C13H11F2N5O2S: C, 46.02; H, 3.27; N, 20.64. Found:
C, 46.25; H, 3.49; N, 20.37.
1.65; N, 17.50.
2.4.6. Date for 8f
Yeild: 46.6%; mp 233–234 °C; 1H NMR (400 MHz, DMSO-d6): d
2.61 (s, 3H, CH3), 2.84 (s, 3H, CH3), 7.32–7.67 (m, 2H, Ar-H), 7.68
(m, 2H, Ar-H), 11.79 (s, 1H, NH); EI MS: m/z (%) 407 ([M+2], 4),
405 (M+, 9), 214 (10), 182 (13), 141 (12), 125 (11), 91 (100). Anal.
Calcd for C14H11ClF3N5O2S: C, 41.44; H, 2.73; N, 17.26. Found: C,
41.63; H, 2.46; N, 17.62.
2.4.15. X-ray diffraction analysis of 8e
Colorless blocks of 8e (0.20 ꢀ 0.10 ꢀ 0.10 mm) were counted
on a quartz fiber with protection oil. Cell dimensions and intensi-
ties were measured at 298 2 K on a Bruker SMART CCD area
2.4.7. Date for 8g
Yeild: 37.1%; mp 176–177 °C; 1H NMR (400 MHz, DMSO-d6): d
2.53 (s, 3H, CH3), 2.84 (s, 3H, CH3), 7.12–7.40 (m, 4H, Ar-H), 7.75
(s, 1H, Het-H), 10.96 (s, 1H, NH); EI MS: m/z (%) 321 (M+, 100),
257 (14), 109 (13). Anal. Calcd for C13H12FN5O2S: C, 48.59; H,
3.76; N, 21.79. Found: C, 48.81; H, 3.94; N, 21.96.
detector diffractometer with graphite monochromated Mo K
a
radiation (k = 0.71073 Å); hmax = 25.99; 12085 measured reflec-
tions; 3112 independent reflections (Rint = 0.0700) of which
2508 had I >2r(I). Data were corrected for Lorentz and polariza-
2.4.8. Date for 8h
tion effects and for absorption (Tmin = 0.8959; Tmax = 0.9944).
The structure was solved by direct methods using SHELXS-
2001,17 all other calculations were performed with Bruker SAINT
System and Bruker SMART programs.18 Full-matrix least-squares
Yeild: 39.6%; Mp 209–210 °C; 1H NMR (400 MHz, DMSO-d6): d
2.65 (s, 3H, CH3), 2.80 (s, 3H, CH3), 3.64 (s, 3H, CH3), 7.46–7.72
(m, 3H, Ar-H), 11.09 (s, 1H, NH); EI MS: m/z (%) 431 ([M+2]+, 23),
430 ([M+1]+, 35), 405 (M+, 69), 394 (100), 362 (36), 333 (33), 308
(29), 153 (29). Anal. Calcd for C15H13Cl2N5O4S: C, 41.87; H, 3.05;
N, 16.28. Found: C, 42.20; H, 2.92; N, 16.26.
refinement based on F2 using the weight of 1/[
r
2(Fo2) +
R =
0.1697, and GOF(F) = 0.583. Hydrogen atoms were observed and
(0.0849P)2 + 0.0555P] gave final values of R = 0.0654,
x
refined with
parameter.
a fixed value of their isotropic displacement
2.4.9. Date for 8i
Yeild: 43.5%; mp 151–152 °C; 1H NMR (400 MHz, DMSO-d6): d
2.96 (s, 3H, CH3), 7.13–7.36 (m, 4H, Ar-H), 8.64 (s, 1H, Het-H),
11.12 (s, 1H, NH); EI MS: m/z (%) 376 ([M+1]+, 11), 375 (M+, 100),
110 (70), 82 (30). Anal. Calcd for C13H9F4N5O2S: C, 41.60; H, 2.42;
N, 18.66. Found: C, 41.99; H, 2.35; N, 18.97.
2.5. Determination of ki value against A. thaliana AHAS
he expression and purification of wild-type A. thaliana AHAS was
performed as described in existing method.19,20 During purification
of AHAS, the inhibitory activities of the synthesized compounds
against wild-type A. thaliana AHAS activity was assayed using the
colorimetric method of Singh et al. exactly as described previously.20
The optimized assay contained pyruvate (100 mM), ThDP (1 mM),
2.4.10. Date for 8j
Yeild: 26.4%; mp 241–242 °C; 1H NMR (400 MHz, DMSO-d6): d
2.97 (s, 3H, CH3), 7.36–7.53 (m, 3H, Ar-H), 8.65 (s, 1H, Het-H),
11.20 (s, 1H, NH); EI MS: m/z (%) 426 ([M+1]+, 11), 425 (M+, 33),
392 (84), 390 (96), 389 (100), 162 (40), 160 (82). Anal. Calcd for
MgCl2 (10 mM), and FAD (10 lM) in 50 mM of potassium phosphate
buffer at pH 7.5. The DMSO solutions of different concentrations of
compounds were used for the assay. The final amount of DMSO in
the assay mixture was kept under four percent so that the effect of
DMSO on the reaction can be ignored. After pre-incubation at room
temperature for 5 min, the reaction was initiated by the addition of
AHAS enzyme. Then, after incubation at 37 °C for 1 h, the reaction
was stopped by the addition of sufficient H2SO4 (3 M). Upon incuba-
tion at 60 °C for 15 min, the enzymatic product of AHAS activity, 2-
acetolactate, is converted to acetoin. Acetoin was then quantified by
further incubation at 60 °C for 15 min in the presence of 0.5% crea-
C
13H8Cl2F3N5O2S: C, 36.64; H, 1.89; N, 16.43. Found: C, 36.99; H,
1.53; N, 16.78.
2.4.11. Date for 8k
Yeild: 26.1%; mp 148–149 °C; 1H NMR (400 MHz, CDCl3): d 3.11
(s, 3H, CH3), 6.80–8.03 (m, 3H, Ar-H), 7.58 (s, 1H, Het-H), 8.04 (s,
1H, NH); EI MS: m/z (%) 393 (M+, 100), 308 (22), 161 (22), 128
(61), 101 (28). Anal. Calcd for C13H8F5N5O2S: C, 39.70; H, 2.05; N,
17.81. Found: C, 40.12; H, 1.97; N, 18.25.
tine and 0.5%
the data to equation:
a
-naphthol. The kai pp values were determined by fitting
2.4.12. Date for 8l
Yeild: 25.5%; mp 165–166 °C; 1H NMR (600 MHz, DMSO-d6): d
2.60 (s, 3H, CH3), 2.97 (s, 3H, CH3), 7.41 (s, 1H, Het-H), 7.51 (d,
1H, J = 8.4 Hz, Ar-H), 7.62 (s, 1H, Ar-H), 7.51 (d, 1H, J = 9.0 Hz, Ar-
H), 10.04 (s, 1H, NH); EI MS: m/z (%) 406 ([M+1], 12.5), 405 (M+,
25.4), 404 ([Mꢁ1], 22.5), 370 (100), 369 (87.0), 305 (14.9), 195
(24.3), 148 (23.0), 106 (29.6), 91 (5.85). Anal. Calcd for
mi
¼
m1 þ ðm0
ꢁ
m1Þ=ð1 þ ½Iꢃ=kapp
Þ
i
In this equation, mi and m0 represent the rates in the presence or
absence of the test compound, respectively, and [I] is the concen-
tration of the compound. The kai pp is apparent inhibition constant,
that is, the concentration of inhibitor giving 50% inhibition. If the
initial analysis indicated that the residual activity (m1) at a saturat-
ing inhibitor concentration is not significantly greater than zero,
C14H11ClF3N5O2S: C, 41.44; H, 2.73; N, 17.26. Found: C, 41.12; H,
2.67; N, 17.05.
the data reanalyzed with the m1 = 0. kapp was calculated by non-
2.4.13. Date for 8m
i
Yeild: 29.2%; mp 178–179 °C; 1H NMR (600 MHz, DMSO-d6): d
2.19 (s, 3H, CH3), 2.54 (s, 3H, CH3), 3.35 (s, 3H, CH3), 7.21–7.25
linear least-squares and the Simplex method for error
minimization.